FDA Ephedra Ban REVERSED by US Court…
Opinion by Consumer Advocate Tim Bolen
Thursday, April 14th, 2005
There is no question that the the US Food & Drug Administration (FDA) is owned and operated as an adjunct to Big Pharma. It is.
FDA executives are at the beck and call of Planet Earth’s pharmaceutical industry. They don’t even bother to hide that fact. FDA leaders see their role as four things: (1) get as many mega-dangerous drugs as possible approved as fast as possible, with the least amount of testing, (2) turn a blind eye towards, and cover up as much negative drug information (adverse reaction) as possible (3) act as a marketing partner for Big Pharma, (4) use their authority to attack, and harass, Big Pharma’s competitors for health dollars.
The US FDA is one of “Medicine’s” top war tools in the battle raging, worldwide, between the forces for “Health” versus “Medicine.” All over the US, flak-jacketed FDA thugs, accompanied by other government agencies, smash their way into “health” related establishments, screaming, battering, scattering, seizing, grabbing – establishing emotional and financial chaos to anyone who dares to compete with Big Pharma’s interests – with some effect.
Despite this “health” is winning, everywhere.
One of Big Pharma’s major competitors is the vitamin/supplement industry. Big Pharma wants to stop it, or slow it as much as possible, and they have two major tools working for them: (1) the US FDA, and (2) “Codex.”
We’ll talk more about “Codex” later.
The FDA, not long ago, attacked the supplement industry, using the ruse that “Ephedra,” an ingredient commonly used in supplements worldwide for hundreds of years, was somehow so suddenly dangerous that it needed to be taken off the market, immediately. And, a ruse it was…
But yesterday, a Federal Judge in Utah smacked the FDA right in the face, hard. Read the press release below…
To read the whole article, including the Judge’s decision, click on the URL below:
http://www.quackpotwatch.org/opinionpieces/FDA%20Ephedra%20Ban%20Reversed.htm
